Home › Idiopathic Thrombocytopenic Purpura › Oregon › Portland
Idiopathic Thrombocytopenic Purpura clinical trials in Portland, OR
4 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Oregon Health & Science University, Portland
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Oregon Health & Science University, Portland
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
RecruitingPhase 1
- Oregon Health & Science University, Portland
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
RecruitingPhase 3
- Oregon Health and Sciences University, Portland
Idiopathic Thrombocytopenic Purpura trials in other cities
- Los Angeles, CA7 studies
- Washington, DC6 studies
- Greenville, NC6 studies
- Boston, MA6 studies
- The Bronx, NY5 studies
- Durham, NC4 studies
- Rochester, MN4 studies
- Seattle, WA4 studies
- Houston, TX4 studies
- New Haven, CT3 studies
- Cedar Rapids, IA3 studies
- New Orleans, LA3 studies
Other studies in Portland
- Non-Small Cell Lung Cancer46 studies
- Cancer (all types)34 studies
- Breast Cancer33 studies
- Prostate Cancer33 studies
- Metastatic Cancer29 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Acute Myeloid Leukemia25 studies
- Endometrial Cancer24 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.